learn about the latest bipolar disorder research at mount sinai. our team of researchers is dedicated to translating findings into clinical care.
learn how bipolar disorder treatment, including medication, therapy, and lifestyle changes, can help you manage symptoms and improve your quality of life.
many people think that participating in a research study means they will get better treatment for their condition. while this may be true, it’s important to remember that a research … continued
background and objectives for the systematic review bipolar disorder is a serious mental illness.
learn about bipolar disorder, including types, symptoms, and treatment options
purpose of review to assess the effectiveness of drug and nondrug therapies for treating acute mania or depression symptoms and preventing relapse in adults with bipolar disorder (bd) diagnoses, including bipolar i disorder (bd-i), bipolar ii disorder (bd-ii), and other types. key messages acute mania treatment: lithium, asenapine, cariprazine, olanzapine, quetiapine, risperidone, and ziprasidone may modestly improve acute mania symptoms in adults with bd-i.
new treatments for bipolar disorder are on the horizon. here’s a look at some of the latest advances, as well as experimental therapies.
we generate breakthrough discoveries that advance scientific understanding and lead to new interventions for preventing and treating bipolar disorder.
bipolar disorder is a chronic mood disorder that causes intense shifts in mood, energy levels and behavior. manic episodes are the main sign of the co
a study covering the 20 years between 1997 and 2016 shows that substantial changes have occurred in the way doctors are treating outpatients diagnosed with bipolar disorder. among a number of important changes, one in particular stands out: a much smaller fraction of outpatients today are being treated with a mood stabilizer and a greater fraction are being treated with a second-generation antipsychotic medication.
who fact sheet on bipolar disorder, including key facts, symptoms and patterns, risks and protective factors, treatment and care, and who response.
bipolar disorder treatment continues to improve. here are the latest findings.
va hsr&d research topics
bipolar disorder news. read the latest medical research on causes, symptoms and new treatments for bipolar disorder.
for people with bipolar disorder, a new way to measure the impact of treatment may be to measure the size of the “spikes” in their measures of mood and mania
background bipolar disorder is a common psychiatric disorder with a massive psychological and social burden. research indicates that treatment adherence is not good in these patients. the families’ knowledge about the disorder is fundamental for managing their patients’ disorder. the purpose of the present study was to investigate the knowledge of the family members of a sample of iranian patients with bipolar i disorder (bd-i) and to explore the potential reasons for treatment non-adherence. methods this study was conducted by qualitative content analysis. in-depth interviews were held and open-coding inductive analysis was performed. a thematic content analysis was used for the qualitative data analysis. results the viewpoints of the family members of the patients were categorized in five themes, including knowledge about the disorder, information about the medications, information about the treatment and the respective role of the family, reasons for pharmacological treatment non-adherence, and strategies applied by families to enhance treatment adherence in the patients. the research findings showed that the family members did not have enough information about the nature of bd-i, which they attributed to their lack of training on the disorder. the families did not know what caused the recurrence of the disorder and did not have sufficient knowledge about its prescribed medications and treatments. also, most families did not know about the etiology of the disorder. conclusion the lack of knowledge among the family members of patients with bd-i can have a significant impact on relapse and treatment non-adherence. these issues need to be further emphasized in the training of patients’ families. the present findings can be used to re-design the guidelines and protocols in a way to improve treatment adherence and avoid the relapse of bd-i symptoms.
bipolar disorders are common, recurrent mental health conditions of variable severity that are difficult to diagnose. affected individuals have higher rates of other mental health disorders, substance use disorders, and comorbid chronic medical illnesses. new diagnostic criteria and specifiers with attention on mixed features and anxious distress aid the physician in recognizing episode severity and prognosis. physicians should consider bipolar disorder in any patient presenting with depression. pharmacotherapy with mood stabilizers, such as lithium, anticonvulsants, and antipsychotics, is a first-line treatment that should be continued indefinitely because of the risk of patient relapse. active lifestyle approaches include good nutrition, exercise, sleep hygiene, and proper weight management. monotherapy with antidepressants is contraindicated during episodes with mixed features, manic episodes, and in bipolar i disorder. ongoing management involves monitoring for suicidal ideation, substance use disorders, treatment adherence, and recognizing medical complications of pharmacotherapy. psychotherapy is a useful adjunct to pharmacotherapy. patients and their support systems should be educated about the chronic nature of this illness, possible relapse, suicidality, environmental triggers (e.g., seasonal light changes, shift work, other circadian disruption), and the effectiveness of early intervention to reduce complications.
related news large-scale study of brain volume finds genetic links to parkinson’s disease and adhd october 21, 2024 new grant funds study on role of brain’s reward system in autism […]
living with bipolar disorder comes with various challenges for both you and your loved ones. these organizations and websites offer information and support.
backgroundbipolar disorder (bd) is predominantly treated with psychotropic drugs, but bd is a complex medical condition and the contribution of psychotropic ...
engaging people with bipolar disorder and translating their experiences into scientific research will help move from hope to real improvements in treatment.
this mental health condition causes extreme mood swings that include emotional highs, called mania, and lows, known as depression.
bipolar disorder is a brain disorder that includes extreme mood shifts. learn about symptoms and treatment.
the pandemic increased our collective focus on mental health, driving research into conditions such as bipolar disorder.
learn about nimh research on bipolar disorder. find resources on the signs and symptoms of bipolar disorder, types, and potential treatments and therapies.
how psychologists’ understanding of bipolar disorder has changed over the past 3 decades and how those changes have led to earlier and more accurate diagnosis and increasingly personalized treatments.
baylor college of medicine received nearly $10 million in funding from the nih brain initiative to study effective treatments for the depressive phase...
explore innovative treatments for bipolar disorder mood swings and energy shifts. discover new hope for managing this challenging condition.
background when assessing the value of an intervention in bipolar disorder, researchers and clinicians often focus on metrics that quantify improvements to core diagnostic symptoms (e.g., mania). providers often overlook or misunderstand the impact of treatment on life quality and function. we wanted to better characterize the shared experiences and obstacles of bipolar disorder within the united states from the patient’s perspective. methods we recruited 24 individuals diagnosed with bipolar disorder and six caretakers supporting someone with the condition. participants were involved in treatment or support services for bipolar disorder in central texas. as part of this qualitative study, participants discussed their everyday successes and obstacles related to living with bipolar disorder during personalized, open-ended interviews. audio files were transcribed, and nvivo software processed an initial thematic analysis. we then categorized themes into bipolar disorder-related obstacles that limit the patient’s capability (i.e., function), comfort (i.e., relief from suffering) and calm (i.e., life disruption) (liu et al., febclin orthop 475:315–317, 2017; teisberg et al., mayacad med 95:682–685, 2020). we then discuss themes and suggest practical strategies that might improve the value of care for patients and their families. results issues regarding capability included the struggle to maintain identity, disruptions to meaningful employment, relationship loss and the unpredictable nature of bipolar disorder. comfort related themes included the personal perception of diagnosis, social stigma and medication issues. calm themes included managing dismissive doctors, finding the right psychotherapist and navigating financial burdens. conclusions qualitative data from patients with bipolar disorder helps identify gaps in care or practical limitations to treatment. when we listen to these individuals, it is clear that treatments must also address the unmet psychosocial impacts of the condition to improve patient care, capability and calm.
bipolar ii disorder is characterised by a pattern of depressive episodes and hypomanic episodes, which are less severe than full-blown mania.
bipolar disorder is a serious mental health condition that affects more than 40 million people worldwide. while bipolar disorder research has historically been underfunded, three family philanthropies recently announced they are donating $150 million to launch a new initiative known as bd2: breakthr
bipolar disorder is a mental illness characterized by extreme mood swings, including episodes of mania and depression. these mood swings can affect a person
patients from across the country will be recruited to take part in a major trial examining a new treatment for bipolar disorder.
background in mental health care, clinical practice is often based on the best available research evidence. however, research findings are difficult to apply to clinical practice, resulting in an implementation gap. to bridge the gap between research and clinical practice, patients’ perspectives should be used in health care and research. this study aimed to understand the challenges people with bipolar disorder (bd) experience and examine what these challenges imply for health care and research needs. methods two qualitative studies were used, one to formulate research needs and another to formulate healthcare needs. in both studies focus group discussions were conducted with patients to explore their challenges in living with bd and associated needs, focusing on the themes diagnosis, treatment and recovery. results patients’ needs are clustered in ‘disorder-specific’ and ‘generic’ needs. specific needs concern preventing late or incorrect diagnosis, support in search for individualized treatment and supporting clinical, functional, social and personal recovery. generic needs concern health professionals, communication and the healthcare system. conclusion patients with bd address disorder-specific and generic healthcare and research needs. this indicates that disorder-specific treatment guidelines address only in part the needs of patients in everyday clinical practice.
this mental health condition causes extreme mood swings that include emotional highs, called mania, and lows, known as depression.
a multidisciplinary team of researchers based at yale will launch a series of studies aimed at accelerating understanding of bipolar disorder and generating new
global perspectives on bipolar disorder treatment: in-depth comparative analysis of international guidelines for medication selection - volume 10 issue 3
bipolar disorder research program (bdrp) at musc, directed by dr. james (jim) prisciandaro, uses mri and pharmacology to understand and treat bipolar disorder.